Compare · head to head
Myriad Genetics vs Nextpower
Nextpower ranks higher overall — 360 rank 96 vs 12.
Nextpower leads on Quality (69 vs 62), Growth (58 vs 44), Safety (69 vs 16) and Sentiment (66 vs 30). The two are close on Value.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Industrial Goods |
| Industry | Biotechnology | Electrical Equipment |
| Size | Medium | Large |
| ISIN | US62855J1043 | US65290E1010 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 12 | 96 |
| Value | 51 | 47 |
| Quality | 62 | 69 |
| Growth | 44 | 58 |
| Safety | 16 | 69 |
| Sentiment | 30 | 66 |
| Quality details | ||
| Profitability | 56 | 82 |
| Cash Truth | 69 | 56 |
Myriad Genetics vs NateraMyriad Genetics vs Rigel PharmaceuticalsMyriad Genetics vs National ResearchMyriad Genetics vs LifeStance HealthAdd a third stock →
Full analyses: Myriad Genetics · Nextpower
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100